cases among all facial paralysis, followed by trauma and infection related ones. 6 The condition is resultant of damage caused to the seventh cranial nerve which travels through the bony Fallopian canal in the skull, providing nerve impulse to the muscles on each sides of the face and tear glands. Additionally, the facial nerve also transmits taste sensations from the tongue. 5 The Ayurvedic term for facial paralysis irrespective of the aetiology is Ardita. 7 Cause-based classification of facial paralysis according to conventional medicine 2, 8, 9 is:
Idiopathic: Bell's palsy, sarcoidosis, inherited Bell's palsy, myasthenia gravis, multiple sclerosis, temporal arteritis.
Infection: External otitis, varicella zoster, syphilis, otitis media, poliomyelitis, botulism, mastoiditis, coxsackievirus, tetanus, diptheria, HIV, cholesteatoma, Lyme disease.
Neoplastic: Schwannoma, teratoma, meningioma, von Recklinghausen's disease, hemangioma, parotid tumour, acoustic neuroma, sarcoma, carcinoma (metastatic).
Metabolic: Diabetes mellitus, Hypertension, Acute porphyria.
Congenital: Möbius syndrome, Dystrophia myotonica.
Autoimmune syndrome: Thrombotic thrombocytopenic purpure, Kawasaki disease, Guillian barre/Miller-Fisher syndrome.
Neurological: Opercular syndrome, Wernicke-Korsakoff syndrome, pseudo-tumour cerebri, lacunar infarct.
Iatrogenic: Post-immunisation, Antitetanus serum, Vaccine for rabies.
Trauma : Traumatic delivery, parotid surgery, mastoid surgery, forceps delivery, anaesthetic nerve block, mandible fracture, penetrating injury, scuba diving.
Toxins : Ethylene glycol, ethanol, Carbon monoxide, thalidomide.
Patho-physiological classification of facial paralysis is of two types namely supranuclear palsy and infranuclear palsy. The former is identified as the involvement of the central nervous system when the fibres of facial nerve proximal to facial nucleus in pons are involved. The causes are mainly due to cerebrovascular stroke, haemorrhage or tumour in the region. In infranuclear palsy, the involvement of peripheral nervous system is identified, when the facial nerve is affected after its nucleus in pons. Bell's palsy and parotid tumours are most common in this category. The renowned Ayurvedic surgeon of ancient times and father of discrete surgery Susruta who lived in the first century AD, describes medication for Ardita in his compendium -Susruta Samhita. His treatment protocol gives special emphasis to Nasya. 15 Conventional medicine offers various treatments for facial paralysis according to the aetiology. In the management of facial paralysis which include Bell's palsy, acute measures are normally taken first. These typically include eye protection such as application of eye ointment or lubricant 16 and wearing watch-glass bandages 17 to prevent dehydration of the cornea or from aberrations.
Subsequently, Mime and physiotherapy including massage and relaxation may be advised to control the condition. Further, medication with steroids or antiviral agents may be prescribed. In some cases, acupuncture, transcutaneous electrical stimulation, transmastoid decompression, surgical methods such as Gold weight implant, facial nerve cable grafting, subperiostal facial suspension (face lifting),or Botulinum toxin injection are performed.
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The conventional medical treatment and management of facial paralysis has its own limitations. It has been reported that in some cases up to 10% of patients are reported to have no recovery from the condition. 20 Some studies have found that the facial paralysis is treatable to a complete cure in the early stages of development of symptoms. 19, 21 However, there are no known definite recommendations favoring any specific medication that could be regarded as the best. 18 In the light of this fact, availability of evidence based alternative medication would be of help to the patients.
The administration of nasal instillation medicine in Ayurveda is called Nasya which belongs to the 5-prong Ayurvedic treatment modality known as Panchakarma. Nasya is regarded as patient friendly because it can be done even in the comfort of patients' residence. Moreover, the use of Nasya medication has not been reported as causing any side effects. The usual dose varies between two to 10 drops in each nostril, once or twice daily. 23 Currently there is a dearth of easy to access evidence on the prevalence of use of Nasya for treating facial paralysis as well as on the effectiveness of Nasya for treating facial paralysis. A search of leading databases of published medical studies, including PubMed, Cochrane and DHARA found no systematic review on either the prevalence of use of Nasya for treating facial paralysis or / and the effectiveness of different nasal instillation Ayurvedic medicines for treating facial paralysis. In the absence of a systematic review existing on the topic, the review will fill a knowledge gap and facilitate practitioners of Ayurveda and Integrative medicine using Nasya as an alternative treatment modality in a way that is informed by evidence. 
Inclusion criteria

Types of participants
Adults (18-70 years of age) with Ardita (chronic or acute) are the participants to be included in this review. More specifically, the review will consider for inclusion studies that have examined the effectiveness of Naysa for treating acute or chronic Ardita in adults. An inclusive approach will be adopted with respect to geographical location of the participants with patients located in any country, and both rural and urban areas to be considered. Participants of any socio-economic status, both sexes and all ethnic origins will be considered.
Studies whose participants have been pregnant women, adults older than 70 years and patients with allergic rhinitis, fever, intracranial tumour/haemorrhage and bilateral facial palsy will be excluded from the review. The reason for the lower age limit of 18 is because oil based Nasya is not usually administered to children, according to the ancient textual source Astanga Hridaya Sootra Sthanna.
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Types of intervention(s) and comparator(s)
The review will include for consideration all quantitative studies conducted worldwide that have examined the effectiveness of nasal instillation of Ayurvedic oil-based herbal medicine. All studies that quantified the effectiveness of Nasya either administered by a therapist or by self administration in treating facial paralysis will be considered for inclusion. All dosages and frequencies of Nasya use will be considered and if possible how effectiveness varies with dosage and frequency of use will be detailed in the analysis.
All studies in which the comparator was conventional medical management or placebo will be considered for inclusion. However, studies of Ayurvedic Nasya medicine in conjunction with conventional medicine, if any, will be excluded. As the objective is not only to shed light on the effectiveness of Nasya for treating facial paralysis, but also the effectiveness of one kind of Nasya medicine compared to another, all studies that have compared the effectiveness of one Nasya instillation medicine compared to another will be considered.
Types of outcomes
The review will consider both Ayurvedic and Conventional medicine outcome assessment criterion as described in the research papers. With respect to the conventional medicine this will include, but not be limited to facial function as measured by the House-Brackmann grading 24, 25 of facial function measure. With respect to the Ayurvedic medicine approach this will include but not limited to Ayurvedic diagnostic scoring.
14, 22
The House-Brackmann scale ranges between I (normal movement) and VI (no movement). 
Types of studies
To answer the questions of whether Nasya is effective for treating facial paralysis in the population of interest and the relative effectiveness of the different Nasya that emerge as effective, the review will consider experimental and epidemiological study designs including randomized controlled trials, non-randomized controlled trials and quasi-experimental studies.
Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilized in the review. An initial limited search of MEDLINE and CINAHL will be undertaken followed by analysis of the text words contained in the title and abstract, and of the index terms used to describe articles. Second, a search using all identified keywords and index terms will then be undertaken, across all databases. Thirdly, the reference list of identified reports and articles will be searched for additional studies. If missing information in studies are found all efforts will be made to obtain them. A limitation of the proposal is that even though it is understood that there may be a number of studies that are published in languages besides English, only studies published in English will be considered. This is due to concerns about the cost and feasibility associated with translation.
The following databases will be searched to identify published studies: Studies published in English language will be considered for inclusion.
Examples of initial keywords that will be used in the exploratory stage of the search for studies in electronic databases are: Nasya, Ardita, Panchakarma and Ayurveda.
Informed by the findings from the initial exploratory searches in the range of databases to be covered, further key words will be identified and a detailed search strategy will be developed and implemented for each database.
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using standardized critical appraisal instruments from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBIMAStARI) (Appendix I). Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer.
Data collection
Data will be extracted from papers included in the review using the standardized data extraction tool from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives.
Data synthesis
Quantitative data will, where possible, will be pooled in statistical meta-analysis using JBIMAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Where statistical pooling is not possible the findings will be presented in narrative form. Tables and figures will be used to aid in data presentation where appropriate.
